Cooley Secures Dismissal With Prejudice for Aurinia Pharmaceuticals
August 13, 2024
August 13, 2024
PALO ALTO, California, Aug. 13 -- Cooley, a law firm, issued the following news release:
San Diego - Cooley secured a dismissal with prejudice for Aurinia Pharmaceuticals (Aurinia), a Canada-based company focused on developing therapies to treat autoimmune diseases, in a securities class action challenging numerous public statements made over a period of nine months.
The US District Court for the District of Maryland granted Cooley's motion to dismiss with prejudic . . .
San Diego - Cooley secured a dismissal with prejudice for Aurinia Pharmaceuticals (Aurinia), a Canada-based company focused on developing therapies to treat autoimmune diseases, in a securities class action challenging numerous public statements made over a period of nine months.
The US District Court for the District of Maryland granted Cooley's motion to dismiss with prejudic . . .